| Category | Name | IntersectionWithQuery | PValue | GenesInTerm | GenesInQuery | GenesInTermInQuery | ID |
|---|---|---|---|---|---|---|---|
| GeneOntologyMolecularFunction | histone acetyltransferase binding | 3.81e-04 | 29 | 20 | 2 | GO:0035035 | |
| GeneOntologyMolecularFunction | nuclear estrogen receptor binding | 1.27e-03 | 53 | 20 | 2 | GO:0030331 | |
| GeneOntologyMolecularFunction | nuclear retinoic acid receptor binding | 1.37e-03 | 55 | 20 | 2 | GO:0042974 | |
| GeneOntologyMolecularFunction | transcription corepressor activity | 1.47e-03 | 229 | 20 | 3 | GO:0003714 | |
| GeneOntologyMolecularFunction | transcription coregulator activity | 2.10e-03 | 562 | 20 | 4 | GO:0003712 | |
| GeneOntologyMolecularFunction | DNA-binding transcription factor binding | 2.39e-03 | 582 | 20 | 4 | GO:0140297 | |
| GeneOntologyMolecularFunction | damaged DNA binding | 3.16e-03 | 84 | 20 | 2 | GO:0003684 | |
| GeneOntologyMolecularFunction | transcription coactivator activity | 3.26e-03 | 303 | 20 | 3 | GO:0003713 | |
| GeneOntologyMolecularFunction | protein-macromolecule adaptor activity | 4.89e-03 | 1160 | 20 | 5 | GO:0030674 | |
| GeneOntologyMolecularFunction | chromatin binding | 5.62e-03 | 739 | 20 | 4 | GO:0003682 | |
| GeneOntologyMolecularFunction | transcription factor binding | 6.00e-03 | 753 | 20 | 4 | GO:0008134 | |
| GeneOntologyMolecularFunction | RNA polymerase II-specific DNA-binding transcription factor binding | 7.92e-03 | 417 | 20 | 3 | GO:0061629 | |
| GeneOntologyCellularComponent | filamentous actin | 6.18e-06 | 38 | 20 | 3 | GO:0031941 | |
| GeneOntologyCellularComponent | actin filament | 3.49e-04 | 146 | 20 | 3 | GO:0005884 | |
| Domain | CH | 2.18e-03 | 65 | 20 | 2 | SM00033 | |
| Domain | CH | 2.52e-03 | 70 | 20 | 2 | PF00307 | |
| Domain | - | 2.59e-03 | 71 | 20 | 2 | 1.10.418.10 | |
| Domain | Prefoldin | 2.66e-03 | 72 | 20 | 2 | IPR009053 | |
| Domain | CH | 2.74e-03 | 73 | 20 | 2 | PS50021 | |
| Domain | CH-domain | 2.88e-03 | 75 | 20 | 2 | IPR001715 | |
| Pubmed | Genetic variations strongly influence phenotypic outcome in the mouse retina. | 2.43e-06 | 46 | 20 | 3 | 21779340 | |
| Pubmed | Gene repressive activity of RIP140 through direct interaction with CDK8. | 3.14e-06 | 5 | 20 | 2 | 21868449 | |
| Pubmed | Large-scale characterization of HeLa cell nuclear phosphoproteins. | 3.54e-06 | 774 | 20 | 6 | 15302935 | |
| Pubmed | 2.44e-05 | 13 | 20 | 2 | 11266503 | ||
| Pubmed | MED25 is distinct from TRAP220/MED1 in cooperating with CBP for retinoid receptor activation. | 2.85e-05 | 14 | 20 | 2 | 17641689 | |
| Pubmed | Multiplexed molecular interactions of nuclear receptors using fluorescent microspheres. | 2.85e-05 | 14 | 20 | 2 | 11500849 | |
| Pubmed | 5.93e-05 | 20 | 20 | 2 | 11877444 | ||
| Pubmed | 6.55e-05 | 21 | 20 | 2 | 19596656 | ||
| Pubmed | WDR76 Co-Localizes with Heterochromatin Related Proteins and Rapidly Responds to DNA Damage. | 6.81e-05 | 394 | 20 | 4 | 27248496 | |
| Pubmed | 1.09e-04 | 27 | 20 | 2 | 26469385 | ||
| Pubmed | 1.18e-04 | 28 | 20 | 2 | 24880616 | ||
| Pubmed | Multiplexed kinase interactome profiling quantifies cellular network activity and plasticity. | 1.36e-04 | 910 | 20 | 5 | 36736316 | |
| Pubmed | 1.96e-04 | 36 | 20 | 2 | 15717329 | ||
| Pubmed | A field synopsis on low-penetrance variants in DNA repair genes and cancer susceptibility. | 2.07e-04 | 37 | 20 | 2 | 19116388 | |
| Pubmed | 2.07e-04 | 37 | 20 | 2 | 34147029 | ||
| Pubmed | The in vivo Interaction Landscape of Histones H3.1 and H3.3. | 3.59e-04 | 608 | 20 | 4 | 36089195 | |
| Pubmed | Systematic analysis of human protein complexes identifies chromosome segregation proteins. | 4.09e-04 | 1155 | 20 | 5 | 20360068 | |
| Pubmed | 4.30e-04 | 638 | 20 | 4 | 31182584 | ||
| Pubmed | Comprehensive analysis of DNA repair gene variants and risk of meningioma. | 4.92e-04 | 57 | 20 | 2 | 18270339 | |
| Pubmed | A genome-wide study of common SNPs and CNVs in cognitive performance in the CANTAB. | 5.09e-04 | 58 | 20 | 2 | 19734545 | |
| Pubmed | Mapping the Ku Interactome Using Proximity-Dependent Biotin Identification in Human Cells. | 5.48e-04 | 283 | 20 | 3 | 30585729 | |
| Cytoband | Ensembl 112 genes in cytogenetic band chr21q21 | 1.29e-03 | 122 | 20 | 2 | chr21q21 | |
| Coexpression | IZADPANAH_STEM_CELL_ADIPOSE_VS_BONE_DN | 9.70e-07 | 107 | 19 | 4 | M4913 | |
| Coexpression | GSE7509_UNSTIM_VS_FCGRIIB_STIM_DC_UP | 6.73e-06 | 174 | 19 | 4 | M6817 | |
| Coexpression | GSE5679_CTRL_VS_RARA_AGONIST_AM580_TREATED_DC_DN | 1.17e-05 | 200 | 19 | 4 | M6556 | |
| Coexpression | DACOSTA_UV_RESPONSE_VIA_ERCC3_COMMON_DN | 1.65e-05 | 466 | 19 | 5 | M13522 | |
| Coexpression | DACOSTA_UV_RESPONSE_VIA_ERCC3_DN | 2.25e-05 | 856 | 19 | 6 | M4500 | |
| Coexpression | HASLINGER_B_CLL_WITH_MUTATED_VH_GENES | 7.56e-05 | 18 | 19 | 2 | M11120 | |
| Coexpression | KRAS.PROSTATE_UP.V1_UP | 1.27e-04 | 137 | 19 | 3 | M2902 | |
| ToppCell | 3'_v3-Lung-Lymphocytic_Invariant-Inducer-like-ILC3|Lung / Manually curated celltypes from each tissue | 8.47e-07 | 167 | 20 | 4 | 0614d077b47a87f726068615548d0b0a216627be | |
| ToppCell | 3'_v3-lymph-node_spleen-Lymphocytic_Invariant-Inducer-like-ILC3|lymph-node_spleen / Manually curated celltypes from each tissue | 1.25e-06 | 184 | 20 | 4 | 479e60f76c191253e23699c9dd7ef7efc08c59ad | |
| ToppCell | PCW_05-06-Mesenchymal-Mesenchymal_myocytic|PCW_05-06 / Celltypes from embryonic and fetal-stage human lung | 1.39e-06 | 189 | 20 | 4 | b6d5dec55bf352f6ae19d8f488ae70aa10fb9a8f | |
| ToppCell | renal_papilla_nuclei-Adult_normal_reference-Mesenchymal-Myocytic_interstitial_cell-Myofibroblast|Adult_normal_reference / Celltypes from Cells and Nuclei per compartment and clinical group | 1.42e-06 | 190 | 20 | 4 | f5fb989afabb49d64d91324570cd8c80a4b9e67d | |
| ToppCell | renal_papilla_nuclei-Adult_normal_reference-Mesenchymal-Myocytic_interstitial_cell-Myofibroblast-|Adult_normal_reference / Celltypes from Cells and Nuclei per compartment and clinical group | 1.42e-06 | 190 | 20 | 4 | 562ee3b025c29edf07b8b344323edb49d82f1c7e | |
| ToppCell | droplet-Large_Intestine-COLON_PROXIMAL|Large_Intestine / Large_Intestine_Pancreas_Liver - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 1.45e-06 | 191 | 20 | 4 | 60c986d2dcbc19d9338c03da6cb5e1d92fd48f8e | |
| ToppCell | droplet-Large_Intestine-COLON_PROXIMAL-30m-Epithelial|Large_Intestine / Large_Intestine_Pancreas_Liver - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 1.45e-06 | 191 | 20 | 4 | 09db184cb90fe282a14474d7217068c58092c6f8 | |
| ToppCell | droplet-Large_Intestine-COLON_PROXIMAL-30m|Large_Intestine / Large_Intestine_Pancreas_Liver - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 1.45e-06 | 191 | 20 | 4 | 973117730d6ba5f127e7a0bfabfd0ff2ca7ac131 | |
| ToppCell | Transverse-(3)_ILC-(30)_ILC|Transverse / shred on region, Cell_type, and subtype | 1.74e-06 | 200 | 20 | 4 | 528520dc98775aca6cc7568fedf5906ea55e0bea | |
| ToppCell | Transverse-(3)_ILC|Transverse / shred on region, Cell_type, and subtype | 1.74e-06 | 200 | 20 | 4 | c1ad7cb012e1c8911e417f7d64ca662c4f5010e0 | |
| ToppCell | Transverse-ILC|Transverse / Region, Cell class and subclass | 1.74e-06 | 200 | 20 | 4 | eb04d6ad2270d3d9ac3d1fae1bb9bedc6fca38fe | |
| ToppCell | Transverse-ILC-ILC|Transverse / Region, Cell class and subclass | 1.74e-06 | 200 | 20 | 4 | 60ec185df2f1989bf8febf75b11c46a576829be3 | |
| ToppCell | TCGA-Bone_and_Soft_Tissue-Primary_Tumor-Sarcoma-Conventional_Leiomyosarcoma|TCGA-Bone_and_Soft_Tissue / Sample_Type by Project: Shred V9 | 4.21e-05 | 153 | 20 | 3 | ec6fe6b8c884fa76adc7a0f9db041f7b1567a2ee | |
| ToppCell | remission-unassigned|remission / disease stage, cell group and cell class | 4.30e-05 | 154 | 20 | 3 | 4130769829b838cc8a075c87ff6c187f0f507f8b | |
| ToppCell | 3'_v3-GI_small-bowel-Lymphocytic_Invariant-Inducer-like-ILC3|GI_small-bowel / Manually curated celltypes from each tissue | 5.37e-05 | 166 | 20 | 3 | 773673a5d0430640439845b264740bfbbdad0cb2 | |
| ToppCell | 3'_v3-GI_small-bowel-Lymphocytic_Invariant-Inducer-like|GI_small-bowel / Manually curated celltypes from each tissue | 5.47e-05 | 167 | 20 | 3 | 3ae46c6363da76c8e1f5579e6027bf88ed637a44 | |
| ToppCell | COVID-19-lung-RBC|COVID-19 / Disease (COVID-19 only), tissue and cell type | 6.28e-05 | 175 | 20 | 3 | 4c35292ad2ac712ba7516f27dd6eac6ba8fdd163 | |
| ToppCell | facs-Marrow-KLS-18m-Lymphocytic-late_pro-B_cell|Marrow / Spleen_Marrow_Thymus - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 6.39e-05 | 176 | 20 | 3 | 3766e0533b103ec92ac75eba3df02e287efc53fa | |
| ToppCell | facs-Marrow-KLS-18m-Lymphocytic-late_pro_B_cell|Marrow / Spleen_Marrow_Thymus - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 6.39e-05 | 176 | 20 | 3 | aa1bada2175d8370fc71939a607407155259d195 | |
| ToppCell | 368C-Lymphocytic-NK_cells-NK_cell_E|Lymphocytic / Donor, Lineage, Cell class and subclass (all cells) | 6.50e-05 | 177 | 20 | 3 | 946803293a7955116c80f403e99e4093e798ca3f | |
| ToppCell | cellseq2-Mesenchymal-Fibroblastic-Fibroblastic_2-ASMC|cellseq2 / Celltype signatures by Technology, Lineage, Lineage_subclass, Celltype_group, Cell_type2 | 6.61e-05 | 178 | 20 | 3 | 8ec2a25dda96c9cc9c2904b6cb18f75a293f4969 | |
| ToppCell | cellseq2-Mesenchymal-Fibroblastic-Fibroblastic_2|cellseq2 / Celltype signatures by Technology, Lineage, Lineage_subclass, Celltype_group, Cell_type2 | 6.61e-05 | 178 | 20 | 3 | 6c91331196696e0cf239d105f458e3230659fa38 | |
| ToppCell | wk_08-11-Mesenchymal-Myofibro_&_SMC-ACTC+_SMC|wk_08-11 / Celltypes from embryonic and fetal-stage human lung | 7.29e-05 | 184 | 20 | 3 | 39168ca2bbf1369c9fe87c67f0aaff5e3cd03151 | |
| ToppCell | 3'_v3-lymph-node_spleen-Lymphocytic_Invariant-Inducer-like|lymph-node_spleen / Manually curated celltypes from each tissue | 7.29e-05 | 184 | 20 | 3 | d97471a4fe17cba6880ccf1a04cc00c741558124 | |
| ToppCell | Fetal_29-31_weeks-Immune-enucleated_erythrocyte-D150|Fetal_29-31_weeks / Lineage, Cell type, age group and donor | 7.41e-05 | 185 | 20 | 3 | c4bf3ac684c1a8876b51f7af4d3a62dc47e961ee | |
| ToppCell | Fetal_29-31_weeks-Immune-enucleated_erythrocyte-D088|Fetal_29-31_weeks / Lineage, Cell type, age group and donor | 7.41e-05 | 185 | 20 | 3 | e8f7da9641b6cf1db1093b4f301ce828fd3a529c | |
| ToppCell | wk_20-22-Hematologic-Meg-ery-Definitive_reticulocyte|wk_20-22 / Celltypes from embryonic and fetal-stage human lung | 7.41e-05 | 185 | 20 | 3 | 4a2c85e292d4cbce80e92992ded5d66a3aa446ee | |
| ToppCell | Immune-enucleated_erythrocyte|World / Lineage, Cell type, age group and donor | 7.53e-05 | 186 | 20 | 3 | f9d5ec5cc8fd6e63bf25abe390307ec8a4a2d5a3 | |
| ToppCell | PCW_05-06-Mesenchymal-Mesenchymal_myocytic-mes_ASM_(13)|PCW_05-06 / Celltypes from embryonic and fetal-stage human lung | 7.77e-05 | 188 | 20 | 3 | 74f7d216209cabdc96b2d46685b0ae017fdcc8fc | |
| ToppCell | Fetal_29-31_weeks-Immune-enucleated_erythrocyte|Fetal_29-31_weeks / Lineage, Cell type, age group and donor | 7.89e-05 | 189 | 20 | 3 | 1900e574870fc647bfa11c732a72f3d38aab717c | |
| ToppCell | LA-13._Vascular_Smooth_Muscle|World / Chamber and Cluster_Paper | 7.89e-05 | 189 | 20 | 3 | 6b3e88751b95fc2173f2c3d5061ed632d0c5f01c | |
| ToppCell | PCW_07-8.5-Mesenchymal-Mesenchymal_myocytic-mes_ASM_(13)|PCW_07-8.5 / Celltypes from embryonic and fetal-stage human lung | 7.89e-05 | 189 | 20 | 3 | da9ecc0d7b81c1901f30f97bb44112dc85444a66 | |
| ToppCell | PBMC-Control-cDC_4|Control / Compartment, Disease Groups and Clusters | 8.27e-05 | 192 | 20 | 3 | 385061d6257295bd515dea98f9bcd52374509276 | |
| ToppCell | ILEUM-inflamed-(7)_Endothelial_cell-(7)_Lymphatics|(7)_Endothelial_cell / shred on tissue, inflammation_status, cell class(v3), cell subclass (v2) | 8.27e-05 | 192 | 20 | 3 | d43caf42ec744e895137f31ef65a990e250669d2 | |
| ToppCell | 10x5'-lymph-node_spleen-Lymphocytic_Invariant-Inducer-like-ILC3|lymph-node_spleen / Manually curated celltypes from each tissue | 8.27e-05 | 192 | 20 | 3 | e16035b3328f9b1b2e28d234c62ba88387540550 | |
| ToppCell | T_cells-CD56_bright_CD16-_NK_cells|T_cells / Immune cells in Kidney/Urine in Lupus Nephritis | 8.40e-05 | 193 | 20 | 3 | 826457e2aafdb61ead8a0a44d8cf9088d310684b | |
| ToppCell | ILEUM-inflamed-(6)_ILC|inflamed / shred on tissue, inflammation_status, cell class(v3), cell subclass (v2) | 8.53e-05 | 194 | 20 | 3 | 4d51d49366c34ff1241770b4acc0167a43b3155a | |
| ToppCell | ILEUM-inflamed-(6)_ILC3|inflamed / shred on tissue, inflammation_status, cell class(v3), cell subclass (v2) | 8.66e-05 | 195 | 20 | 3 | c6968da7d2b60c2163e1ff0ffa41340e1ec1d2ed | |
| ToppCell | Children_(3_yrs)-Immune-monocyte-D032|Children_(3_yrs) / Lineage, Cell type, age group and donor | 8.66e-05 | 195 | 20 | 3 | 81a28289eda1a8a1a31b7357106f64ac5000e172 | |
| ToppCell | COVID-19_Mild-Classical_Monocyte-cMono_4|COVID-19_Mild / Disease condition and Cell class | 8.79e-05 | 196 | 20 | 3 | 3729d1444c65cad640377894decc64129bc3fd5b | |
| ToppCell | 5'-GW_trimst-1.5-SmallIntestine-Mesenchymal-myocytic-SMC_(PLPP2+)|GW_trimst-1.5 / Celltypes from developing, pediatric, Crohn's, & adult GI tract | 8.92e-05 | 197 | 20 | 3 | f4f686d20821af3e6f859b96edc31827a430e3de | |
| ToppCell | Tracheal-NucSeq-Stromal-Myofibroblastic-Muscle_smooth_pulmonary|NucSeq / Cell types per location group and 10X technology with lineage, and cell group designations | 8.92e-05 | 197 | 20 | 3 | ac4f53acb2f8a428b0f2fab3c30a34e095a1bed7 | |
| ToppCell | Tracheal-NucSeq-Stromal-Myofibroblastic|NucSeq / Cell types per location group and 10X technology with lineage, and cell group designations | 9.06e-05 | 198 | 20 | 3 | c12e7511628db819a52959bb68580e27c00c2e41 | |
| ToppCell | (11)_FOXN4+-(2)_GFP_FOXI1|(11)_FOXN4+ / shred by cell type by condition | 9.06e-05 | 198 | 20 | 3 | 76d40b8c2f8399725b3a62ee2ae0896559cf91eb | |
| ToppCell | Tracheal-NucSeq-Stromal-Myofibroblastic-Muscle_smooth_airway_ASM|NucSeq / Cell types per location group and 10X technology with lineage, and cell group designations | 9.06e-05 | 198 | 20 | 3 | 22e766df1276c5b14aa0d83f434f47140ebb98ea | |
| ToppCell | (02)_MMP9/10+-(2)_GFP_FOXI1|(02)_MMP9/10+ / shred by cell type by condition | 9.19e-05 | 199 | 20 | 3 | 18a7f9ced4364f45b184bd529f32ef02c27779d3 | |
| ToppCell | (01)_IL1RL1+-(2)_GFP_FOXI1|(01)_IL1RL1+ / shred by cell type by condition | 9.19e-05 | 199 | 20 | 3 | a2f7d0cabf35b80fe239fae34a77bf9344d5d743 | |
| ToppCell | Brain_organoid-organoid_Tanaka_cellReport-2m-Macroglial|2m / Sample Type, Dataset, Time_group, and Cell type. | 9.33e-05 | 200 | 20 | 3 | ec5c7d90c2eab408f66f920a3f7d9041c40d1179 | |
| ToppCell | (3)_ILC|World / shred on Cell_type and subtype | 9.33e-05 | 200 | 20 | 3 | 03554b3f323785b1e0b48fa32de0d92065dd798e | |
| ToppCell | LPS_anti-TNF-Endothelial-Endothelial-Artery|LPS_anti-TNF / Treatment groups by lineage, cell group, cell type | 9.33e-05 | 200 | 20 | 3 | b1ff8d61b567f85006d6d20093f9c803b6d34674 | |
| ToppCell | (30)_ILC|World / shred on Cell_type and subtype | 9.89e-05 | 204 | 20 | 3 | bd9fbd278c05e396463704d711b60d47699e3c09 | |
| ToppCell | Substantia_nigra-Macroglia-POLYDENDROCYTE-P1-P1_1-Trf-Oligodendrocyte.Tfr.Ctps_(Ctps)|Substantia_nigra / BrainAtlas - Mouse McCarroll V32 | 2.75e-04 | 55 | 20 | 2 | 0b62b4f438a493a30bddb99e1eadd20c92704ee9 | |
| ToppCell | Substantia_nigra-Macroglia-POLYDENDROCYTE-P1-P1_1-Trf|Substantia_nigra / BrainAtlas - Mouse McCarroll V32 | 2.75e-04 | 55 | 20 | 2 | fa556ea954ea868a4b23e410f3b27d69e04794ee | |
| ToppCell | 367C-Lymphocytic-CD8+_Cytotoxic_T-cell-CD8+_Cytotoxic_T_cell_4|CD8+_Cytotoxic_T-cell / Donor, Lineage, Cell class and subclass (all cells) | 4.45e-04 | 70 | 20 | 2 | 37e34ef782b253c43628d5bb2fe5e0294573d0ef | |
| ToppCell | frontal_cortex-Neuronal-GABAergic_neuron-Lamp5-Lamp5_Fam19a1_Pax6|frontal_cortex / Per Region, Lineage, Cell class, Cell type, Cell subtype | 1.32e-03 | 121 | 20 | 2 | 7f2057367777c6c92f596054cbc5fe567d079fbc | |
| ToppCell | Mild/Remission-B_naive-1|World / disease group and sub_cluster of B and Plasma cells(res = 0.5) | 1.32e-03 | 121 | 20 | 2 | 68940a552233d255b90ce5a081339c0d9d46ab02 | |
| ToppCell | primary_visual_cortex-Neuronal-GABAergic_neuron-Lamp5-Lamp5_Fam19a1_Tmem182|primary_visual_cortex / Per Region, Lineage, Cell class, Cell type, Cell subtype | 1.39e-03 | 124 | 20 | 2 | 690595d710b57b7cff8029a3bb06a8dd7e3c03c1 | |
| ToppCell | frontal_cortex-Neuronal-GABAergic_neuron-Lamp5-Lamp5_Fam19a1_Tmem182|frontal_cortex / Per Region, Lineage, Cell class, Cell type, Cell subtype | 1.52e-03 | 130 | 20 | 2 | 8bd038b0423960ffdc6c8b128c46a55386f9c58c | |
| ToppCell | PBMC-Mild-Lymphocyte-B-B_cell-B_naive-B_naive-1|Mild / Location, Disease Group, Cell group, Cell class and sub_cluster (2021.03.01) | 1.54e-03 | 131 | 20 | 2 | a3a086ce6e69707ca6a042f3b15c130f81909acb | |
| ToppCell | TCGA-Bone_and_Soft_Tissue-Primary_Tumor-Sarcoma-Conventional_Leiomyosarcoma-2|TCGA-Bone_and_Soft_Tissue / Sample_Type by Project: Shred V9 | 1.57e-03 | 132 | 20 | 2 | a8e7e7f38af095d63e221bcc06a1e5147bb6e467 | |
| ToppCell | COVID-19-kidney-Technical/muscle|COVID-19 / Disease (COVID-19 only), tissue and cell type | 1.74e-03 | 139 | 20 | 2 | 13247bcb21c57c808657e0f543d6f134eeea7cc1 | |
| ToppCell | TCGA-Bladder-Solid_Tissue_Normal-Urothelial_normal_tissue-Urothelial_normal_tissue-2|TCGA-Bladder / Sample_Type by Project: Shred V9 | 1.79e-03 | 141 | 20 | 2 | 1baa054c2ae3b446d1954244b7fbf8af824ef345 | |
| ToppCell | Parenchymal-10x3prime_v2-Stromal-Pericyte-Muscle_pericyte_systemic|10x3prime_v2 / Cell types per location group and 10X technology with lineage, and cell group designations | 1.79e-03 | 141 | 20 | 2 | dcc56aef1b31bfe0de84cb0b5c77d242681cf19c | |
| ToppCell | Fetal_29-31_weeks-Endothelial-endothelial_cell_of_bronchial_vessel-D150|Fetal_29-31_weeks / Lineage, Cell type, age group and donor | 1.86e-03 | 144 | 20 | 2 | 748f4efc59f7afbce6c497524f36d852b8b1d637 | |
| ToppCell | Fetal_29-31_weeks-Endothelial-endothelial_cell_of_bronchial_vessel|Fetal_29-31_weeks / Lineage, Cell type, age group and donor | 1.91e-03 | 146 | 20 | 2 | df865558d1843f3857ebd1529cebc540d3554c59 | |
| ToppCell | 10x_3'_v3-thymus_(10x_3'_v3)-lymphocytic-innate_lymphocytic-immature_natural_killer_cell|thymus_(10x_3'_v3) / Per Platform+tissue_group, by lineage_subgroup, cell_group, cell_type | 1.91e-03 | 146 | 20 | 2 | 40fac8a298152ec7f7eeeed5a2d28541aea3b338 | |
| ToppCell | (0)_Normal/No_Treatment-(4)_COL2.3+_osteoblasts|World / Stress and Cell class | 1.94e-03 | 147 | 20 | 2 | 87c24843cb0e87ad42e725d08423131a5d2d25a3 | |
| ToppCell | Smart-seq2-spleen_(Smart-seq2)-lymphocytic-innate_lymphocytic-innate_lymphoid_cell|spleen_(Smart-seq2) / Per Platform+tissue_group, by lineage_subgroup, cell_group, cell_type | 1.96e-03 | 148 | 20 | 2 | f90ee6fbd71b5e0512af34867202f38409f4de38 | |
| ToppCell | Children_(3_yrs)-Immune-dendritic_cell-D032|Children_(3_yrs) / Lineage, Cell type, age group and donor | 2.07e-03 | 152 | 20 | 2 | 0769857f25da2e6169420818e61d65e33b7277b1 | |
| ToppCell | COVID-19_Mild-PLT_0|World / Disease Group and Platelet Clusters | 2.07e-03 | 152 | 20 | 2 | d49f7c0681500fc4d93818d47e8e8afb726c23d9 | |
| ToppCell | mild_COVID-19_(asymptomatic)-MAIT|World / disease group, cell group and cell class (v2) | 2.10e-03 | 153 | 20 | 2 | 2b4c69f6db17927d6506a645ac058133e60b0103 | |
| ToppCell | mild_COVID-19_(asymptomatic)-MAIT|mild_COVID-19_(asymptomatic) / disease group, cell group and cell class (v2) | 2.10e-03 | 153 | 20 | 2 | 26852f3d8f80e102e24bcb90e24aac26fdc9a32c | |
| ToppCell | Control-PLT_4|World / Disease Group and Platelet Clusters | 2.12e-03 | 154 | 20 | 2 | a2a03c5e6759c45aeeedf1e68ecb5a0112ef9a20 | |
| ToppCell | 390C-Lymphocytic-NK_cells-NK_cell_E|390C / Donor, Lineage, Cell class and subclass (all cells) | 2.15e-03 | 155 | 20 | 2 | 98d8432739965dd1ab77c899cb6321f7f05eaa46 | |
| ToppCell | remission-unassigned|World / disease stage, cell group and cell class | 2.15e-03 | 155 | 20 | 2 | d81bec894381e3e2d6249a567e8108b8423e5c54 | |
| ToppCell | 10x5'-bone_marrow-Lymphocytic_Invariant-Inducer-like-ILC3|bone_marrow / Manually curated celltypes from each tissue | 2.15e-03 | 155 | 20 | 2 | 83430a64c2cb5ad29caa3dacba76c28dd204ac40 | |
| ToppCell | 10x5'-GI_large-bowel-Lymphocytic_T_CD4-Teffector/EM_CD4|GI_large-bowel / Manually curated celltypes from each tissue | 2.18e-03 | 156 | 20 | 2 | 01f2c0c6a936dfb59bc727feef428a906ad2a80b | |
| ToppCell | facs-Marrow-KLS-18m-Hematologic-megakaryocyte-erythroid_progenitor_cell|Marrow / Spleen_Marrow_Thymus - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 2.23e-03 | 158 | 20 | 2 | 0edd9b005875f9a4f5446f5d5161f8ba63860793 | |
| ToppCell | facs-Marrow-KLS-18m-Hematologic-megakaryocyte-erythroid_progenitor_cell|Marrow / Spleen_Marrow_Thymus - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 2.23e-03 | 158 | 20 | 2 | 9fd77ebdd1babf1c85a85d38d9a15858ab08bc84 | |
| ToppCell | primary_visual_cortex-Neuronal-GABAergic_neuron-Lamp5-Lamp5_Lsp1|primary_visual_cortex / Per Region, Lineage, Cell class, Cell type, Cell subtype | 2.26e-03 | 159 | 20 | 2 | 0dccc4275b9b4f8554dd556da7218e130bff8fd1 | |
| ToppCell | PND07-Immune-Immune_Lymphocytic_T/NK-Lymphocytic_T-CD8_T-CD8_T_prolif|PND07 / Age_group by Lineage, Lineage_subclass, Cell_type, subtypes-by-prolif | 2.26e-03 | 159 | 20 | 2 | 8d958d79f5eb3ab683d1245ae7f4f22a2cefbc55 | |
| ToppCell | TCGA-Bladder-Solid_Tissue_Normal|TCGA-Bladder / Sample_Type by Project: Shred V9 | 2.29e-03 | 160 | 20 | 2 | d6678996e12eaf2b735f1dfae32418cb2fabf268 | |
| ToppCell | TCGA-Bladder-Solid_Tissue_Normal-Urothelial_normal_tissue-Urothelial_normal_tissue|TCGA-Bladder / Sample_Type by Project: Shred V9 | 2.29e-03 | 160 | 20 | 2 | 8a41e2c96e0e170ac35daf6c403bf961b8d7c30b | |
| ToppCell | TCGA-Bladder-Solid_Tissue_Normal-Urothelial_normal_tissue|TCGA-Bladder / Sample_Type by Project: Shred V9 | 2.29e-03 | 160 | 20 | 2 | c8dc575562b463fd30832d322c28006f18f7ab9c | |
| ToppCell | (1)_Control_(PBS)-(4)_COL2.3+_osteoblasts|(1)_Control_(PBS) / Stress and Cell class | 2.29e-03 | 160 | 20 | 2 | 8450466fc2465c56798df2b520edd23c2c2e941c | |
| ToppCell | Adult-Mesenchymal-airway_smooth_muscle_cell-D231|Adult / Lineage, Cell type, age group and donor | 2.29e-03 | 160 | 20 | 2 | d783d29150033e9181c0e30870070268fed3fd85 | |
| ToppCell | TCGA-Brain-Primary_Tumor-Low_Grade_Glioma-Astrocytoma|TCGA-Brain / Sample_Type by Project: Shred V9 | 2.35e-03 | 162 | 20 | 2 | 810881210e015c788814e4fe8d7a24c929cf2621 | |
| ToppCell | PBMC_fresh-frozen-Severe-critical_convalescent_d42-56-Lymphocytic-Lymphocytic_ILC-NK_cell-NK_c02-NCAM1|Severe-critical_convalescent_d42-56 / Compartment, severity and other cell annotations on 10x 3' data (130k) | 2.35e-03 | 162 | 20 | 2 | 9b1c07f0af657095379380c39d763cab0ad73e74 | |
| ToppCell | Fetal_29-31_weeks-Immune-mast_cell|Fetal_29-31_weeks / Lineage, Cell type, age group and donor | 2.37e-03 | 163 | 20 | 2 | 03b2ec226adffba3ce893f3d12e549c841e662fd | |
| ToppCell | facs-Lung-ENDOMUCIN-18m-Lymphocytic-CD4-positive,_alpha-beta_T_cell|Lung / Lung_Trachea - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 2.37e-03 | 163 | 20 | 2 | 4af92b211d12c5b88b65bb746242cd702b545bd0 | |
| ToppCell | facs-Lung-ENDOMUCIN-18m-Lymphocytic-CD4+_T|Lung / Lung_Trachea - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 2.37e-03 | 163 | 20 | 2 | d24774e0aa612322c22fdb3b314aef275fa01d68 | |
| ToppCell | frontal_cortex-Neuronal-GABAergic_neuron-Lamp5|frontal_cortex / Per Region, Lineage, Cell class, Cell type, Cell subtype | 2.40e-03 | 164 | 20 | 2 | 08819970174a3eb4eee8e1e675075828665b845e | |
| ToppCell | 15-Airway-Mesenchymal-Airway_Smooth_Muscle|Airway / Age, Tissue, Lineage and Cell class | 2.43e-03 | 165 | 20 | 2 | 531804467601e1ee1f771cffa21501f6d464ae10 | |
| ToppCell | facs-Kidney-nan-3m-Lymphocytic|Kidney / Skin_Bladder_Kidney_Mammary_Gland - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 2.43e-03 | 165 | 20 | 2 | ba041deb0d9c187f251493ccd4794b5f09abd5aa | |
| ToppCell | 10x5'-blood-Lymphocytic_Invariant-Inducer-like-ILC3|blood / Manually curated celltypes from each tissue | 2.43e-03 | 165 | 20 | 2 | f012a27ece54c0f7b73a2f4f89c6ee8b865f8782 | |
| ToppCell | LV-13._Vascular_Smooth_Muscle|World / Chamber and Cluster_Paper | 2.43e-03 | 165 | 20 | 2 | f37fd95adc95d7753cf6e55ae819976513c7ec77 | |
| ToppCell | renal_medulla_nuclei-Renal_AKI_(acute_kidney_injury)-Epithelial-Proximal_tubule_epithelial_cell-kidney_proximal_tubule_epithelial_cell_cycling-Cycling_Proximal_Tubule_Epithelial_Cell_low-phase|Renal_AKI_(acute_kidney_injury) / Celltypes from Cells and Nuclei per compartment and clinical group | 2.46e-03 | 166 | 20 | 2 | 43f84d3cd58e93ce00c241656c4cba27604b4932 | |
| ToppCell | NS-critical-d_0-4-Epithelial-unknown_epithelial|d_0-4 / Location, Severity, dps_group, Lineage and Cell class of Upper airway (combined) | 2.46e-03 | 166 | 20 | 2 | dd02bbe4af609c6348dc92417254f4740f2900a8 | |
| ToppCell | Dendritic_Cells-Donor_02|World / lung cells shred on cell class, cell subclass, sample id | 2.46e-03 | 166 | 20 | 2 | fbeb74b98b58085de323f744b18d4a8f7b22d5d4 | |
| ToppCell | renal_medulla_nuclei-Renal_AKI_(acute_kidney_injury)-Endothelial-blood_vessel_endothelial_cell_of_kidney-arteriolar_vasa-recta_endothelial-Afferent_/_Efferent_Arteriole_Endothelial_Cell|Renal_AKI_(acute_kidney_injury) / Celltypes from Cells and Nuclei per compartment and clinical group | 2.46e-03 | 166 | 20 | 2 | 8e5f2afbeffae5e77fcb29e8fe9f5aa49779b619 | |
| Disease | response to beta blocker, heart rate | 6.81e-04 | 57 | 20 | 2 | EFO_0004326, EFO_0007766 | |
| Disease | intellectual disability (implicated_via_orthology) | 1.18e-03 | 75 | 20 | 2 | DOID:1059 (implicated_via_orthology) | |
| Disease | ovarian carcinoma | 1.27e-03 | 321 | 20 | 3 | EFO_0001075 | |
| Disease | red blood cell density measurement | 2.60e-03 | 880 | 20 | 4 | EFO_0007978 | |
| Disease | Cardiomyopathies | 3.47e-03 | 130 | 20 | 2 | C0878544 | |
| Disease | brain volume measurement | 7.20e-03 | 595 | 20 | 3 | EFO_0006930 | |
| Disease | refractive error, age at onset, Myopia | 7.48e-03 | 193 | 20 | 2 | EFO_0004847, HP_0000545, MONDO_0004892 | |
| Disease | neuropsychological test | 7.79e-03 | 197 | 20 | 2 | EFO_0003926 |
| Peptide | Gene | Start | Entry |
|---|---|---|---|
| MSFSGIFRSSSKESS | 121 | Q9UGJ0 | |
| MKTGFSSSRTLGSSS | 646 | A6NCI8 | |
| TSMSKETSSKTFSFL | 546 | Q8IZF6 | |
| GMKSSKSSTSLAFES | 31 | Q5M775 | |
| TRLKSSSLTFMSTSA | 546 | A0AUZ9 | |
| KKFERTSSSGTMSST | 641 | Q92619 | |
| RRSSSSTGSTKSFNM | 631 | B1AK53 | |
| KMSVSRSSSLKSSSS | 466 | Q9H4H8 | |
| TSSSKLMASKSSATV | 331 | P48552 | |
| TSFQKSNSSSKATTM | 271 | P57087 | |
| SSSEKSKSSGSSRSK | 66 | P46100 | |
| SLSTTSRSGKHSFKM | 456 | Q9UNA4 | |
| SSSSSSSASTSGKMK | 1101 | Q15648 | |
| GSSSSKLSSSMYSSQ | 1121 | Q15648 | |
| KMSRSASESASSSGT | 186 | Q9H902 | |
| SSFMSRTSKSKSGSS | 366 | Q16513 | |
| MKRQLATSSGSSSSS | 581 | O94818 | |
| ASSASSTSLKSKEMS | 291 | Q04724 | |
| SSKSTFSFSMTKPSE | 1146 | P49790 | |
| SSSSSSSKRGKKMCS | 501 | Q01831 | |
| TKTFSSSSSSKKMGS | 706 | P53814 |